Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. immune evasion
Show results for
Products
Services

Companies

News
Articles

Refine by
Locations

  • USA
  • Europe
  • Asia & Middle East
  • Australasia
  • North America
Brands

  • medchemexpress
  • capsidmap
  • context
  • dubermatinib
  • glymab
View all brands

Immune Evasion Equipment & Supplies

14 equipment items found

Dubermatinib - Model (TP-0903) - AXL Inhibitor

Dubermatinib - Model (TP-0903) - AXL Inhibitor

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
Dubermatinib (TP-0903) is an investigational inhibitor of AXL receptor tyrosine kinase (RTK), a protein known to be involved in acquiring resistance to chemotherapeutics, immune evasion, and developing metastatic capacity in cancer ...
CONTACT SUPPLIER

CapsidMap - Adeno-Associated Virus (AAV)

CapsidMap - Adeno-Associated Virus (AAV)

by:Dyno Therapeutics   based inWatertown, MASSACHUSETTS (USA)
Our CapsidMap™ platform uses AI to systematically and rapidly optimize AAV capsids, overcoming the limitations of naturally occurring virus capsids by improving targeting ability, payload size, immune evasion and manufacturability. By building a massive and detailed map of synthetic AAV capsid sequence space, we can quickly navigate the landscape to find ...
CONTACT SUPPLIER

MedChemExpress - Model Acesulfame potassium - 55589-62-3

MedChemExpress - Model Acesulfame potassium - 55589-62-3

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Acesulfame potassium can suppress autophagic degradation of PD-L1 in RIL-175 and SK-Hep1 cells through the ERK1/2-mTORC1-ULK1 pathway, which may be related to immune evasion in cancer cells. Acesulfame potassium can be used in research on neurological diseases, metabolic disorders, cancer, and immune ...
CONTACT SUPPLIER

Txinno Bioscience - Model ENPP1 - Emopamil-Binding Protein (EBP) Inhibitor

Txinno Bioscience - Model ENPP1 - Emopamil-Binding Protein (EBP) Inhibitor

Manufactured by:TxinnoBioscience Inc.   based inYongin-si, SOUTH KOREA
By hydrolyzing cGAMP (natural ligand of STING) into AMP and GMP, ENPP1 negatively regulates STING-mediated type I interferon production and subsequently prevents innate immune response against tumor. It was suggested that cancer cells acquire immune evasiveness by increasing ENPP1 expression, reflecting over-expression of ENPP1 in many different ...
CONTACT SUPPLIER

GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

GlyMab - Model Anti-glycan mAb - Antibodies for Cancer

Manufactured by:Scancell   based inOxford, UNITED KINGDOM
Glycosylation is increasingly recognised as a modulator of the malignant phenotype of cancer cells, where the interaction between cells and the tumour micro-environment is altered to facilitate processes such as drug resistance, metastasis and immune evasion. Antibodies recognising tumour-associated glycans could therefore have excellent therapeutic ...
CONTACT SUPPLIER

Context - Investigational Medicine - Onapristone Extended Release (ONA-XR)

Context - Investigational Medicine - Onapristone Extended Release (ONA-XR)

Manufactured by:Context Therapeutics Inc.   based inPhiladelphia, PENNSYLVANIA (USA)
ONA-XR is an investigational medicine that prevents progesterone signaling by blocking the interaction between progesterone and its binding partner, progesterone receptor. Onapristone is the only known full PR ...
CONTACT SUPPLIER

Immune-Onc - Model IO-108 - (Anti-LILRB2) Mechanisms of Action Program

Immune-Onc - Model IO-108 - (Anti-LILRB2) Mechanisms of Action Program

Manufactured by:Immune-Onc Therapeutics, Inc.   based inPalo Alto, CALIFORNIA (USA)
Immune-Onc is evaluating IO-108, an antagonist antibody targeting the myeloid checkpoint, LILRB2 (also known as ILT4). The U.S. FDA has cleared the IND application for IO-108 as a potential therapy for solid tumors. The company expects to begin clinical trials with IO-108 in the second half of ...
CONTACT SUPPLIER

Regeneus Progenza - Cryopreserved Multi-Synergistic Therapy Targeting Pain and Inflammation

Regeneus Progenza - Cryopreserved Multi-Synergistic Therapy Targeting Pain and Inflammation

Manufactured by:Regeneus Ltd.   based inPaddington, AUSTRALIA
Progenza is a cryopreserved multi-synergistic therapy targeting pain and inflammation. Regeneus has patented techniques and high-quality testing to ensure the production of millions of Progenza™ doses from a single donor (allogeneic). ...
CONTACT SUPPLIER

Dengue Virus Antibodies

Dengue Virus Antibodies

Manufactured by:Bio-Rad Laboratories, Inc. (Antibodies)   based inHercules, CALIFORNIA (USA)
The dengue virus (DENV), first isolated in 1943, is assigned to the family Flaviviridae, genus Flavivirus. It has four serotypes (DENV-1, DENV-2, DENV-3, and DENV-4) and transmission to humans occurs via the Aedes mosquito, mainly Aedes aegypti. Its global reach has mirrored the spread of Aedes aegypti in tropical and subtropical areas (Messina et al. 2014). It is suggested that 390 million ...
CONTACT SUPPLIER

Scopus - Model CO-sTiRNA - Dual-Action STAT3 Inhibitor

Scopus - Model CO-sTiRNA - Dual-Action STAT3 Inhibitor

Manufactured by:Scopus BioPharma   based inNew York, NEW YORK (USA)
Our licensed gene therapy, CO-sTiRNA™, is a dual-action STAT3 inhibitor. STAT3 is a gene that drives tumor cell growth and anti-tumor immune suppression. CO-sTiRNA™ is a highly selective and targeted gene therapy that silences the activity of the STAT3 gene by way of RNA interference. CO-sTiRNA™ also stimulates TLR9 receptors to activate the body’s immune defense to ...
CONTACT SUPPLIER

MedChemExpress - Model Zamaporvint - 1900754-56-4

MedChemExpress - Model Zamaporvint - 1900754-56-4

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
Zamaporvint (RXC004) is an orally active and selective inhibitor of Wnt. Zamaporvint targete membrane-bound o-acyltransferase Porcupine and inhibited Wnt ligand palmitoylation, secretion, and pathway activation. Zamaporvint displays a favorable pharmacokinetic profile and shows potent antiproliferative effects in Wnt ligand-dependent colorectal and pancreatic cell lines. Zamaporvint possesses ...
CONTACT SUPPLIER

MedChemExpress - Model ß-Nicotinamide mononucleotide - 1094-61-7

MedChemExpress - Model ß-Nicotinamide mononucleotide - 1094-61-7

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
β-nicotinamide mononucleotide (β-NM) is a product of the nicotinamide phosphoribosyltransferase (NAMPT) reaction and a key NAD+ intermediate. The pharmacological activities of β-nicotinamide mononucleotide include its role in cellular biochemical functions, cardioprotection, diabetes, Alzheimer's disease, and complications associated with ...
CONTACT SUPPLIER

MedChemExpress - Model N-Nitroso-N-methylurea - 684-93-5

MedChemExpress - Model N-Nitroso-N-methylurea - 684-93-5

Manufactured by:MedChemExpress LLC (MCE)   based inMonmouth Junction, NEW JERSEY (USA)
N-Nitroso-N-methylurea (NMU;MNU;NMH) is a potent carcinogen, mutagen and teratogenand. N-Nitroso-N-methylurea is a direct-acting alkylating agent that interacts with DNA. N-Nitroso-N-methylurea targets multiple animal organs to cause various cancer and/or degenerative disease. N-Nitroso-N-methylurea is also a precursor in the synthesis of ...
CONTACT SUPPLIER

Sumitomo - Immunotherapeutic Cancer Vaccines

Sumitomo - Immunotherapeutic Cancer Vaccines

by:Sumitomo Pharma Oncology, Inc.   based inCambridge, MASSACHUSETTS (USA)
Immunotherapeutic cancer vaccines have generated a lot of interest from oncologists since it was discovered that immune activation can lead to a specific antitumor response.1 However, despite initial progress, most cancer vaccines have failed to drive sufficient tumor immunogenicity, leading to poor clinical responses.1 The reason for this may be that previous vaccine models used inadequate ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT